These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 444672)

  • 1. Hla-matched platelet transfusion therapy of severe aplastic anemia.
    Tosato G; Appelbaum FR; Deisseroth AB
    Blood; 1979 Jul; 54(1):293. PubMed ID: 444672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe aplastic anemia treated with HLA-matched platelet transfusion].
    Nozaki H; Yonekura S; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1986 Aug; 27(8):1410-4. PubMed ID: 3795515
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-leukocyte and anti-platelet immunization and transfusions during aplastic anemias].
    Dausset J; Benbunan M
    Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):132-43. PubMed ID: 781619
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-matched platelet transfusion therapy of severe aplastic anemia.
    Tosato G; Applebaum FR; Deisseroth AB
    Blood; 1978 Oct; 52(4):846-54. PubMed ID: 687832
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of platelet-alloimmunization with cyclosporin A in a patient with aplastic anemia.
    Yamamoto M; Ideguchi H; Nishimura J; Nawata H; Inaba S; Tokunaga K; Kiyokawa H; Maeda Y
    Am J Hematol; 1990 Mar; 33(3):220-1. PubMed ID: 2301381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and circumvention of refractoriness to platelet transfusions: interface between preparative and therapeutic apheresis.
    Beris P; Dornier C
    Curr Stud Hematol Blood Transfus; 1990; (57):267-76. PubMed ID: 2272206
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature.
    Kurtzberg J; Friedman HS; Kinney TR; Chaffee S; Falletta JM
    Am J Med; 1987 Oct; 83(4A):30-3. PubMed ID: 3118706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term support of a patient with aplastic anemia by platelets and granulocytes from donors of a HLA-A,B identical family.
    Kretschmer V; Mueller-Eckhardt C; Pralle H; Mueller-Eckhardt G; Grosse-Wilde H
    Vox Sang; 1979; 37(3):166-9. PubMed ID: 115158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia.
    Wulff JC; Santner TJ; Storb R; Banaji M; Buckner CD; Clift R; Stewart P; Sanders J; Slichter S; Thomas ED
    Vox Sang; 1983; 44(6):366-74. PubMed ID: 6349124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of histocompatibility in platelet transfusion therapy.
    Yankee RA
    Vox Sang; 1971 May; 20(5):419-26. PubMed ID: 4106552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aplastic anemia with antiplatelet iso-antibody and intracerebral hemorrhage--a case report of a child treated by platelet transfusion, splenectomy and craniotomy (author's transl)].
    Fukazawa K; Nagao T; Kuwana N; Pak S; Juji T; Shibata Y
    Rinsho Ketsueki; 1980 Nov; 21(11):1761-6. PubMed ID: 7206230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histocompatibility and thrombocyte transfusion].
    Mueller-Eckhardt C
    Blut; 1977 Apr; 34(4):261-70. PubMed ID: 851647
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.
    Herzig RH; Herzig GP; Bull MI; Decter JA; Lohrmann HP; Stout FG; Yankee RA; Graw RG
    Blood; 1975 Nov; 46(5):743-50. PubMed ID: 1174708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic aplastic anemia treated with methyltestosterone and fresh platelets.
    BELLANTI JA; PINKEL D
    JAMA; 1961 Oct; 178():70-3. PubMed ID: 13866868
    [No Abstract]   [Full Text] [Related]  

  • 19. Collection, preservation and transfusion of platelets; with special reference to the factors affecting the survival rate and the clinical effectiveness of transfused platelets.
    STEFANINI M; DAMESHEK W
    N Engl J Med; 1953 May; 248(19):797-802. PubMed ID: 13046615
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.